1-(4-Iodobenzyl)piperidine

Catalog No.: 
ACDNAQ134
CAS No.: 
651022-26-3
Molecular Formula: 
C12H16IN
Molecular Weight: 
301.17
1-(4-Iodobenzyl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$97.00InquiryInquiry
250mg95%$190.00InquiryInquiry
1g95%$745.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Iodobenzyl)piperidine
IUPAC Name1-(4-iodobenzyl)piperidine
MDL No.MFCD06797859
Molecular FormulaC12H16IN
Molecular Weight301.17
SMILESIC1=CC=C(C=C1)CN2CCCCC2
InChI KeyUBTQOFNYBSZILI-UHFFFAOYSA-N
Synonym1-(4-IODOBENZYL)PIPERIDINE;Piperidine, 1-[(4-iodophenyl)methyl]-;1-[(4-iodophenyl)methyl]piperidine
CAS No.651022-26-3

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314-H335
Precautionary Statement(s)
P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDNAQ134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDMVC712 route compound structure diagram
    ACDMVC71216004-15-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDNAQ134 route product structure diagram
    ACDNAQ134651022-26-3
Inquiry

2. ACDNAQ134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDNAQ134 route product structure diagram
    ACDNAQ134651022-26-3
Inquiry

3. ACDNAQ134 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDNAQ134 route product structure diagram
    ACDNAQ134651022-26-3
Inquiry

Comments (0)